Dr. Sarah Belderbos
Immunology/ Hyperpol. M&M
Curriculum vitae and Publications
Email: sarah.belderbos( at )med.uni-tuebingen.de
Phone: +49 7071 29 87481
Fax: +49 7071 29 4451
Immunotherapy is a promising strategy in cancer treatment. However, it has shown limited success in many solid tumors. My primary research focus is on elucidating the role of macrophages in this therapeutic strategy to 1) improve tumoral response to immunotherapy and 2) to allow the discovery of novel imaging biomarkers in murine cancer models. To do so, I apply a multimodal, multiparametric and hybrid imaging approach, which for example includes PET/MRI, 13C-lactate hyperpolarized MRI and optical imaging.